These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15598693)

  • 41. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatty liver disease in obese children--relation to other metabolic risk factors.
    Volovelsky O; Weiss R
    Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():59-64. PubMed ID: 21905818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population.
    Sanal MG; Sarin SK
    Diabetes Metab Syndr; 2011; 5(2):76-80. PubMed ID: 22813407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonalcoholic fatty liver and insulin resistance among petrochemical workers.
    Cotrim HP; Carvalho F; Siqueira AC; Lordelo M; Rocha R; De Freitas LA
    JAMA; 2005 Oct; 294(13):1618-20. PubMed ID: 16204660
    [No Abstract]   [Full Text] [Related]  

  • 47. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population.
    Perez M; Gonzáles L; Olarte R; Rodríguez NI; Tabares M; Salazar JP; Jaimes S; García RG; López-Jaramillo P
    Prev Med; 2011 Feb; 52(2):174-7. PubMed ID: 21147154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
    Fenkci S; Rota S; Sabir N; Akdag B
    Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic syndrome from the view point of public health: with special reference to nonalcoholic fatty liver disease.
    Watanabe T; Murata C; Watanabe Y
    Nihon Koshu Eisei Zasshi; 2005 Nov; 52(11):934-42. PubMed ID: 16408478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
    Nestel PJ; Mensink RP
    Curr Opin Lipidol; 2013 Feb; 24(1):1-3. PubMed ID: 23298957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonalcoholic fatty liver disease in overweight children and adolescents.
    Sagi R; Reif S; Neuman G; Webb M; Phillip M; Shalitin S
    Acta Paediatr; 2007 Aug; 96(8):1209-13. PubMed ID: 17655622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
    Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
    Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
    Shieh K; Gilchrist JM; Promrat K
    Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
    Hagymási K; Reismann P; Rácz K; Tulassay Z
    Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women.
    Kim HC; Choi SH; Shin HW; Cheong JY; Lee KW; Lee HC; Huh KB; Kim DJ
    World J Gastroenterol; 2005 Sep; 11(34):5314-21. PubMed ID: 16149138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Dongiovanni P; Santorelli G; Branchi A; Taioli E; Fiorelli G; Fargion S
    Gastroenterology; 2002 Feb; 122(2):274-80. PubMed ID: 11832442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
    Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatic steatosis and fatty pancreas--2 targets of metabolic syndrom in children].
    Aleshina EI; Novikova VP; Gur'eva VA; Burnysheva IA; Usychenko EA
    Eksp Klin Gastroenterol; 2014; (8):16-20. PubMed ID: 25911907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.